Metraipolis › archive › dc_be9edf6e2aab

Therapeutic applications of CRISPR-Cas9 gene editing — Europe PMC PMID:41476860

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41476860
DOI
10.3389/fgeed.2025.1724291
License (as archived)
solo-consultazione
Archived
2026-11-07T15:03:22.072Z
SHA-256 of the archived text
6cdbd63b4eb83dcff2a652e4913ede38241d6bd1c40a7959403ddf8f3ca60f51
Stable URL of this page
https://metraipolis.com/documento/dc_be9edf6e2aab

How to cite

Therapeutic applications of CRISPR-Cas9 gene editing — Europe PMC PMID:41476860 — Europe PMC (en), https://europepmc.org/article/MED/41476860 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be9edf6e2aab (Metraipolis archive dc_be9edf6e2aab, sha256 6cdbd63b4eb83dcff2a652e4913ede38241d6bd1c40a7959403ddf8f3ca60f51)
BibTeX
@misc{dcbe9edf6e2aab,
  title = {Therapeutic applications of CRISPR-Cas9 gene editing — Europe PMC PMID:41476860},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41476860},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be9edf6e2aab; sha256 6cdbd63b4eb83dcff2a652e4913ede38241d6bd1c40a7959403ddf8f3ca60f51},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41476860. Agents can read the archived copy with the MCP tool read_document.